Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
  1. Home
  2. Search

Refine search

Refine search

Access:
Content type:
Publication date:
Apply   From and To filters
Subject: Show more
Journals Show more
Publishers: Show more
Societies Show more
Series: Show more
Collections: Show more

Actions for selected content:

Select all | Deselect all
  • View selected items
  • Export citations
  • Download PDF (zip)
  • Save to Kindle
  • Save to Dropbox
  • Save to Google Drive

Save Search

You can save your searches here and later view and run them again in "My saved searches".

Please provide a title, maximum of 40 characters.
Cancel
×

21 results

Page 1 of 2

Reproductive Medicine for the MRCOG
  • Edited by Siladitya Bhattacharya, Mark Hamilton
  • Published online:
    25 February 2021
    Print publication:
    25 February 2021
  • An authoritative account of the causes of infertility that fully explores the clinical assessment of patients and covers the decision-making behind treatment options. The content follows the MRCOG syllabus as well as delving deeper into subjects covered by the RCOG Advanced Training Skills Modules (ATSMs), leaving readers well prepared for their examinations. Written by nationally recognised leaders in the field, this volume concisely reviews contemporary clinical practice. Using an aetiology-based approach, chapters discuss ovulatory dysfunction, endometriosis, male infertility, uterine/tubal factors and unexplained infertility. The increasing use of third-party reproduction and surrogacy is explored, along with the psychosocial aspects of this type of treatment. Ethical dilemmas surrounding reproductive medicine and their management are covered in depth. With an emphasis on practical approaches to the delivery and organisation of clinical and laboratory services, readers learn how to ensure the support and care they offer is of the highest quality.

Management of Infertility for the MRCOG and Beyond
  • 3rd edition
  • Edited by Siladitya Bhattacharya, Mark Hamilton
  • Published online:
    05 June 2014
    Print publication:
    30 January 2014
  • Demands on the gynaecologist from patients seeking help with suboptimal fertility continue to grow, and fertility-related issues are often in the gaze of the media. Obstetricians and gynaecologists need to ensure that they are up to date, informed and knowledgeable to successfully engage with their patients. Written by nationally recognised leaders in the field, this volume concisely reviews contemporary clinical practice. Using an aetiology-based approach, the evidence underpinning the management of ovulatory dysfunction, male infertility, endometriosis, tubal, uterine factor, and unexplained infertility is critically reviewed. The role of assisted reproduction treatment is elaborated and a new chapter describes the clinical and laboratory techniques involved. The book provides a comprehensive summary for candidates preparing for the Part 2 MRCOG examination, covering the RCOG curriculum for infertility management. It will be enormously helpful to health professionals working in fertility clinics and an essential aide-memoire to those undertaking special interest training in infertility.

  • 7 - Unexplained infertility

  • Edited by Siladitya Bhattacharya, University of Aberdeen, Mark Hamilton
  • Book:
    Management of Infertility for the MRCOG and Beyond
    Published online:
    05 June 2014
    Print publication:
    30 January 2014, pp 77-84

  • Summary

    Expectant management has a key role in the management of unexplained infertility. The decision to treat couples with unexplained infertility should take into account their chances of spontaneous conception, which is affected by female age, duration of infertility and occurrence of a previous pregnancy. The rationale for the use of oral clomifene citrate in unexplained infertility is the belief that it corrects subtle ovulatory dysfunction and encourages the release of more than one oocyte. Clomifene is inexpensive, non-invasive and requires little clinical monitoring, but it can cause multiple pregnancies, including high-order multiples. Intrauterine insemination (IUI) has been used widely for the treatment of unexplained infertility. It is thought to enhance the chance of pregnancy by increasing the number of motile spermatozoa within the uterus, bringing them in close proximity to the oocyte. Although more effective than IUI, superovulation (SO) along with IUI is associated with high rates of multiple births.

  • Preface

  • Edited by Siladitya Bhattacharya, University of Aberdeen, Mark Hamilton
  • Book:
    Management of Infertility for the MRCOG and Beyond
    Published online:
    05 June 2014
    Print publication:
    30 January 2014, pp vii-vii

  • Summary

    Infertility affects up to one in six couples and remains a major cause of distress in both men and women. Concerns about fertility continue to grow across the world along with economic and social pressures causing women to delay childbirth, and the impact of lifestyle factors such as obesity, smoking and alcohol intake.

    The last two decades have witnessed a shift towards evidence-based fertility treatment and greater awareness of the need to ensure the highest standards of safety. Management of infertility has moved away from an aetiological pathway where physicians identify and then treat an underlying pathology, to a prognostic approach where the decision to initiate treatment is driven by awareness of a couple's chances of spontaneous conception and what can be achieved with intervention.

    To address the changes in the way fertility problems are now diagnosed, investigated and managed, we have substantially redesigned the third edition of this book, enlisting a new cast of authors and expanding the scope of the text. While the evidence base underpinning the choice of tests and treatments is sometimes far from secure, clinical decisions should be made jointly with patients and should maximise health gains while minimising costs and risks.

    Infertility remains an integral part of core training for those taking the MRCOG examination. We hope that this book will provide a concise guide to fertility practice for trainees as well as for specialists.

  • 19 - Screening for early ovarian ageing

  • from SECTION 5 - FUTURE FERTILITY INSURANCE: SCREENING, CRYOPRESERVATION OR EGG DONORS?
  • Edited by Susan Bewley, William Ledger, University of New South Wales, Sydney, Dimitrios Nikolaou
  • Book:
    Reproductive Ageing
    Published online:
    05 February 2014
    Print publication:
    01 June 2009, pp 201-210

  • Summary

    A number of tests have been used to predict ovarian ageing/poor ovarian reserve. Despite the large number of tests in current use, an ideal test has yet to be developed. The most comprehensive systematic review for tests of ovarian reserve concluded that an in vitro fertilisation (IVF) cycle itself may be a more reliable predictor of ovarian response to stimulation than any of the existing tests. The predictive value of four of the most commonly used tests are: basal serum follicle-stimulating hormone, antral follicle count (AFC), serum inhibin B and serum antimillerian hormone (AMH). Internationally, a number of fertility prediction tests have been marketed, and the tests have been mainly developed within an IVF setting, using data on outcomes of ovarian stimulation. Serum AMH concentration and AFC tests can predict oocyte yield but not oocyte quality or pregnancy.

Page 1 of 2